BIOMAT Database Logo BIOMAT Database Logo

Comparative hypoglycemic effects of chlorpropamide, tolbutamide, and furfurylurea. 1959

T S DANOWSKI, and F M MATEER

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

T S DANOWSKI, and F M MATEER
ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
July 1964, Medical times,
T S DANOWSKI, and F M MATEER
[Oral hypoglycemic drugs; comparative study of carbutamide, tolbutamide and chlorpropamide].
July 1961, Hospital (Rio de Janeiro, Brazil),
T S DANOWSKI, and F M MATEER
Comparison of acute hypoglycemic potencies of tolbutamide and chlorpropamide.
February 1960, Journal of the American Medical Association,
T S DANOWSKI, and F M MATEER
A comparison of the acute hypoglycemic potencies of tolbutamide and chlorpropamide.
March 1959, Annals of the New York Academy of Sciences,
T S DANOWSKI, and F M MATEER
Comparison of relative hypoglycemic potencies and metabolic effects of metahexamide, chlorpropamide and tolbutamide in diabetes mellitus.
July 1959, Metabolism: clinical and experimental,
T S DANOWSKI, and F M MATEER
Comparative hypoglycemic and hypoketonemic effects of tolbutamide and glypentide in rat.
June 1977, Revista espanola de fisiologia,
T S DANOWSKI, and F M MATEER
Clinical experience with chlorpropamide and comparative evaluation with tolbutamide.
June 1960, Journal of the American Geriatrics Society,
T S DANOWSKI, and F M MATEER
[COMPARATIVE STUDIES ON THE IGT, CHLORPROPAMIDE AND TOLBUTAMIDE TEST].
April 1964, Lijecnicki vjesnik,
T S DANOWSKI, and F M MATEER
Some effects of tolbutamide and chlorpropamide in vitro.
March 1959, Annals of the New York Academy of Sciences,
T S DANOWSKI, and F M MATEER
The comparative pharmacology of tolbutamide, carbutamide, chlorpropamide and metahexamide in man.
July 1959, Metabolism: clinical and experimental,
Copied contents to your clipboard!